Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

Delayed Quote. Delayed  - 09/30 10:06:47 pm
130.02 USD   +1.71%
09/22 ZIMMER BIOMET : Sep 22, 2016 Zimmer Biomet Contributes Additional $1..
09/21 ZIMMER BIOMET H : ex-dividend day
09/20 ZIMMER BIOMET : Sep 20, 2016 Zimmer Biomet Launches VANGUARD® Indivi..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Biomet 3Q Loss Widens On Charges; Sales Grow 5%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/11/2012 | 04:51pm CEST

("Biomet 3Q Loss Widens On Charges; Sales Grow 5%," at 7:03 a.m. EDT, misstated the hip sales increase in the sixth paragraph. The correct version follows:)

Biomet Inc.'s fiscal third-quarter loss widened on merger-related costs as strong sales for sports medicine, extremities and trauma helped drive the orthopedic medical-device maker's top-line growth.

Though privately held, Biomet's results are closely watched because the company reports earlier than larger competitors--such as Zimmer Holdings Inc. (>> Zimmer Holdings, Inc.), Stryker Corp. (SYK) and Johnson & Johnson (>> Johnson & Johnson)--and could foreshadow industry trends.

Biomet has seen its losses widen in recent quarters, weighed down by charges related to its $11.4 billion buyout in 2007 by a private-equity consortium including affiliates from The Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG. Sales have also been weak as patients, worried about out-of-pocket costs or long absences from work to recover, opt to defer hip and knee-replacement procedures. Biomet has said it is unclear when demand will come back.

For the quarter ended Feb. 29, Biomet reported a loss of $16.5 million, compared with a loss of $11.6 million a year earlier. Excluding merger and other special items, adjusted earnings fell to $55.1 million from $63.8 million. Sales jumped 4.5% to $708.9 million.

Gross margin slipped to 69% from 69.3%.

The company, which distributes products in about 90 countries, said worldwide hip sales increased 6%, while worldwide knee sales grew 4%. Sales for sports medicine, extremities and trauma were up 16%, while the spine and bone healing segment saw a 5% drop.

U.S. sales grew 5% while Europe sales rose 2.1%. International sales, which include Canada, South America, Mexico and the Asia-Pacific region, jumped 7.2%.

Last week, Biomet made a binding offer to acquire the global trauma business of Johnson & Johnson's DePuy Orthopaedics Inc. for about $280 million in cash, a deal the company said would greatly expand its sports, extremities and trauma business. Biomet also recently agreed to pay $23 million in penalties to settle U.S. allegations that it bribed doctors in Brazil, China and other countries over a period of years.

--By Anne Pallivathuckal and Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

Stocks mentioned in the article : Zimmer Holdings, Inc., Johnson & Johnson
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ZIMMER BIOMET HOLDINGS INC
09/29 ZIMMER BIOMET : Launches VANGUARD® Individualized Design Knee Replacement
09/28 ZIMMER BIOMET : Contributes Additional $100,000 in Funding to the Orthopaedic Re..
09/22 ZIMMER BIOMET : Sep 22, 2016 Zimmer Biomet Contributes Additional $100,000 in Fu..
09/21 ZIMMER BIOMET HOLDINGS INC : ex-dividend day
09/20 ZIMMER BIOMET : Sep 20, 2016 Zimmer Biomet Launches VANGUARD® Individualized Des..
09/15 ZIMMER BIOMET : Earns EPA Recognition for Converting Warsaw-Indiana Headquarters..
09/15 ZIMMER BIOMET : Sep 15, 2016 Zimmer Biomet Adds 3D Range-of-Motion Simulation Ca..
09/09 ZIMMER BIOMET : Investing in India
09/08 ZIMMER BIOMET : First Minister announces key investment for Wales during visit t..
08/25 ZIMMER BIOMET : Virtual Reality, BattleBots® and Much More Take over Minneapolis..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/29DJMEDTRONIC : FDA Approves Medtronic's New Automated Insulin Pump -- Update
09/28DJMEDTRONIC : FDA Approves Medtronic's New Automated Insulin Pump
09/28DJMEDTRONIC : FDA Approves Medtronic's New Automated Insulin Pump
09/28DJMEDTRONIC : FDA Approves Medtronic's New Automated Insulin Pump
09/17DJJ&J to Buy Abbott Eye Business -- WSJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
09/20 Zimmer Biomet launches VANGUARD Individualized Design Knee Replacement
09/15 Zimmer Biomet acquires Dutch firm Clinical Graphics
08/23 Zimmer Biomet declares $0.24 dividend
08/15 Zimmer Biomet buys musculoskeletal diagnostics testing firm
08/10 Zimmer Biomet prices equity offering; shares off 3% premarket
Advertisement
Financials ($)
Sales 2016 7 703 M
EBIT 2016 2 472 M
Net income 2016 547 M
Debt 2016 10 046 M
Yield 2016 0,72%
P/E ratio 2016 50,83
P/E ratio 2017 19,32
EV / Sales 2016 4,62x
EV / Sales 2017 4,26x
Capitalization 25 570 M
More Financials
Chart ZIMMER BIOMET HOLDINGS INC
Duration : Period :
Zimmer Biomet Holdings Inc Technical Analysis Chart | ZBH | US98956P1021 | 4-Traders
Full-screen chart
Technical analysis trends ZIMMER BIOMET HOL...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 141 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David C. Dvorak President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Robin T. Barney Senior VP-Global Operations & Logistics
Daniel P. Florin Chief Financial Officer & Senior Vice President
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS..24.61%25 570
MEDTRONIC PLC11.02%118 017
BAXTER INTERNATIONAL I..22.99%25 519
C R BARD INC18.11%16 435
SYSMEX CORP-4.74%15 506
TERUMO CORP4.18%14 853
More Results